Related Experiment Videos
Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians
H F Hadidi1, S Cholerton, S C Monkman
1Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid.
Pharmacogenetics
|June 1, 1994
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet.
Pharmacological research·2023
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
Clinical pharmacology and therapeutics·2015
Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection.
Journal of viral hepatitis·2014
Patients benefit from genetics-guided coumarin anticoagulant therapy.
Clinical pharmacology and therapeutics·2014
Is there a need to teach pharmacogenetics?
Clinical pharmacology and therapeutics·2014
Photoinduced radical Truce-Smiles rearrangement driven by halogen bond interactions.
Organic & biomolecular chemistry·2026
Continuous flow electrochemical oxidation of activated methylarenes using O2.
Organic & biomolecular chemistry·2026
Alkyl bromide-promoted photo-methylation of benzaldehydes with DMSO as the methyl source.
Organic & biomolecular chemistry·2026
GRX2-Mediated Deglutathionylation of SIRT3 Alleviates Intestinal Ischemia/Reperfusion-Induced Mitochondrial Oxidative Damage.
Antioxidants & redox signaling·2026
Gain-of-function mutation of type 2 ryanodine receptor attenuates dopaminergic neuron development associated with Ca2+ overload-triggered oxidative damage in mitochondria.
Biochemical and biophysical research communications·2026